Skip to main content
PLOS Medicine logoLink to PLOS Medicine
. 2021 Aug 5;18(8):e1003673. doi: 10.1371/journal.pmed.1003673

Conflict-related intentional injuries in Baghdad, Iraq, 2003–2014: A modeling study and proposed method for calculating burden of injury in conflict

Guy W Jensen 1,*, Riyadh Lafta 2, Gilbert Burnham 3, Amy Hagopian 4, Noah Simon 4, Abraham D Flaxman 4
Editor: Margaret E Kruk5
PMCID: PMC8376016  PMID: 34351908

Abstract

Background

Previous research has focused on the mortality associated with armed conflict as the primary measure of the population health effects of war. However, mortality only demonstrates part of the burden placed on a population by conflict. Injuries and resultant disabilities also have long-term effects on a population and are not accounted for in estimates that focus solely on mortality. Our aim was to demonstrate a new method to describe the effects of both lives lost, and years of disability generated by a given conflict, with data from the US-led 2003 invasion and subsequent occupation of Iraq.

Methods and findings

Our data come from interviews conducted in 2014 in 900 Baghdad households containing 5,148 persons. The average household size was 5.72 persons. The majority of the population (55.8%) were between the ages of 19 and 60. Household composition was evenly divided between males and females. Household sample collection was based on methodology previously designed for surveying households in war zones. Survey questions were answered by the head of household or senior adult present. The questions included year the injury occurred, the mechanism of injury, the body parts injured, whether injury resulted in disability and, if so, the length of disability.

We present this modeling study to offer an innovative methodology for measuring “years lived with disability” (YLDs) and “years of life lost” (YLLs) attributable to conflict-related intentional injuries, using the Global Burden of Disease (GBD) approach. YLDs were calculated with disability weights, and YLLs were calculated by comparing the age at death to the GBD standard life table to calculate remaining life expectancy. Calculations were also performed using Iraq-specific life expectancy for comparison.

We calculated a burden of injury of 5.6 million disability-adjusted life years (DALYs) lost due to conflict-related injuries in Baghdad from 2003 to 2014. The majority of DALYs lost were attributable to YLLs, rather than YLDs, 4.99 million YLLs lost (95% uncertainty interval (UI) 3.87 million to 6.13 million) versus 616,000 YLDs lost (95% UI 399,000 to 894,000). Cause-based analysis demonstrated that more DALYs were lost to due to gunshot wounds (57%) than any other cause.

Our study has several limitations. Recall bias regarding the reporting and attribution of injuries is possible. Second, we have no data past the time of the interview, so we assumed individuals with ongoing disability at the end of data collection would not recover, possibly counting more disability for injuries occurring later. Additionally, incomplete data could have led to misclassification of deaths, resulting in an underestimation of the total burden of injury.

Conclusions

In this study, we propose a methodology to perform burden of disease calculations for conflict-related injuries (expressed in DALYs) in Baghdad from 2003 to 2014. We go beyond previous reports of simple mortality to assess long-term population health effects of conflict-related intentional injuries. Ongoing disability is, in cross section, a relatively small 10% of the total burden. Yet, this small proportion creates years of demands on the health system, persistent limitations in earning capacity, and continuing burdens of care provision on family members.


In a modelling study, Guy Jensen and colleagues propose a method for calculating burden of injury in conflict using data on conflict-related intentional injuries in Baghdad, Iraq 2003-2014.

Author summary

Why was this study done?

  • The Global Burden of Disease (GBD) project, based at the University of Washington, publishes the estimates of prevalence, incidence, years of life lost (YLLs), and years lived with disability (YLDs) for a comprehensive list of diseases and injuries and for all countries from 1990 to the present. The World Health Organization has also published YLL and YLD estimates.

  • Previous researchers innovated the population-proportionate to size sampling methodology for household surveys in war zones, which we used in this study.

  • Previous papers have attempted to calculate only Iraq War deaths, as mortality is an important population health indicator and is relatively straightforward to measure.

  • Injuries are, along with mortality, an important factor in conflict settings; they measure a more nuanced toll on public health. Ongoing disability is important, especially when associated with demands on the health system, ongoing limitations in earning capacity, and the burdens created for family caregivers.

  • We aim to lay out our application of the GBD methodology, along with our alteration to it for calculation of burden of injury in conflict. Additionally, we aim to describe specifically how these calculations were applied in hopes of developing a methodology for the study of conflict populations.

What did the researchers do and find?

  • This study innovates the application of GBD methodology for calculating YLLs and YLDs to data collected in a war zone.

  • We calculated a burden of injury of 5.6 million DALYs lost due to conflict-related injuries in Baghdad from 2003 to 2014. These calculations encompass both mortality as well as the effects of injury and disability on the population of Baghdad. We performed these calculations using a variation of the GBD methodology to better reflect the dynamic nature of conflict.

  • Media reports tend to focus heavily on the more “spectacular” aspects of conflict, such as explosions, shelling, and air strikes. By contrast, our results demonstrate gunshot wounds were the leading contributor to YLDs and YLLs.

What do these findings mean?

  • Our results demonstrate the importance of data-driven, epidemiologically sound assessment of conflicts, especially those spanning multiple years. However, it should be noted that our primary goal was to develop a methodology, demonstrated by our calculations with the city of Baghdad, to allow for its use in other conflicts.

  • With more sophisticated methods, epidemiologists might better prevent the most harmful aspects of conflict for civilian populations, might better predict losses in advance of the onset of conflict, and might contribute to health systems in planning for care delivery.

  • Limitations for this study include the possibility for recall bias among the survey participants as well as the possible undercounting of deaths due to injury due to classifying any injuries that did not definitively result in death as YLDs rather than YLLs. Lastly, we did not adjust for changes in the population of Baghdad over the course of the study.

Introduction

Since the United States–led invasion of Iraq in 2003, the war has expanded to new territories and combatant groups. Attempts to track the health consequences of these events have grown increasingly sophisticated [1,2].

As conflicts in the region have escalated, Iraqi civilians have been displaced and have lost many previous gains in health and life expectancy [35]. Previous papers have attempted to calculate Iraq War deaths, as mortality is an important population health indicator and relatively straightforward to measure [69]. However, injuries and their resulting disabilities are an important factor in conflict settings as they measure a more nuanced effect on public health. Ongoing disability is important, especially when associated with health system demands, ongoing limitations in earning capacity, and the burdens created for family caregivers [10].

Previous papers have reported on interviews conducted during April and May 2014 in 900 households containing 5,148 persons. Elsewhere, we have described the 553 injuries reported by Baghdad residents in this sample population, 225 of which were conflict-related intentional injuries, and 328 were not directly related to conflict [1114]. A third of the injuries reported in our study resulted in death, yet the fatality rate for conflict-related intentional injuries was higher (39%) than for unintentional injuries (7%). The major cause of injuries not related directly to conflict was falls (131), which increased dramatically since 2008, followed by traffic-related injuries (81). The proportion of injuries ending in disabilities remained stable through the 11-year survey period. This work focuses exclusively on conflict-related intentional injuries.

Our aim is to introduce a methodology for measuring disability-adjusted life years (DALYs) in a study of injuries and disabilities in a war setting using the Global Burden of Disease (GBD) methodology. For those who died, we calculated “years of life lost” (YLLs) based on both standard and Iraq-specific life expectancy. For those who survived, we calculated the burden of injury by applying disability weights (DWs) for varying types of injuries. Our intent is to encourage the field of war epidemiology to go beyond simple mortality counts and incorporate more sophisticated measures of injury and disability.

Methods

Data collection

The full methods and results from the initial data collection are previously published by Lafta and colleagues [11]. However, we have summarized our methods here because of the importance of the role of sampling on the ultimate results. We developed an Arabic language questionnaire to collect data on death, injury, and disability based on several previous injury or disability research efforts (S1 Questionnaire) [1517]. Paper forms were used without identifying information. We asked respondents to name the year of the injury, limiting our scope to events between 2003 and 2014. Data were entered in SPSS (IBM, Armonk, New York), and files were rechecked against paper records to resolve discrepancies.

We defined injury as “any intentional or unintentional physical harm that required medical care, whether received or not, and with or without intervention, and which resulted in loss or reduction in normal activities for a period of time.” Disability was defined as “any limitation to normal activities stemming from an injury.” A conflict-related intentional injury was defined as being caused either by criminal activity or armed conflict. Criminal acts were defined as “events caused during robbery, assassinations, kidnapping, hijacking, or assaults likely carried out for personal reasons with the individual being specifically targeted or a bystander to a specifically targeted person.” War or conflict-related events were defined as those occurring “in the course of wider indiscriminate intentional violence whether by militias or organized military and whether for sectarian or in the course of organized military operations.” All injuries analyzed were war related according to the respondents.

One of our authors (RL) organized and trained 2 teams of Iraqi interviewers to administer questionnaires to selected households. The 8 interviewers (4 female, 4 male) and their 2 supervisors were community or family medicine doctors with field data collection experience. Interviews were conducted between May 8 and June 1, 2014.

The population-proportionate-to-size random sample included 30 clusters of 30 households in 14 administrative units in Baghdad, selected using a Google Earth mapping methodology described elsewhere [18].

Sampling

Two-stage cluster sampling techniques were utilized to select 30 random clusters with a start household for each cluster. These clusters were created based on the sampling data for the 14 administrative units within the city of Baghdad. The clusters were created using a probability proportional to estimated size (PPES) technique. Beginning with the start household, teams used a systematic sample technique including every other house until 30 households were interviewed [11]. This sample size of the original survey was designed to measure an injury rate of 1% with a 95% confidence level [11].

Burden of injury methodology

We applied modified GBD and DALY methodologies to this specific conflict-related data set. This work relied on the methods, values, and techniques described in the GBD 2013 study and regularly updated by the Institute for Health Metrics and Evaluation (IHME) [10]. DALYs were calculated by summing the YLLs and years lived with disability (YLDs) from participants due to injuries. The primary outcomes for this work were incidence YLLs and incidence YLDs.

YLDs were calculated by multiplying the duration of disability by DWs as defined for the GBD 2013 study [19]. YLLs were calculated by multiplying deaths by the remaining life expectancy at age of death based on a GBD standard life table for estimating premature mortality, rather than an Iraqi-specific life expectancy [20]. Because life expectancy represents the aspirational healthy life span for all individuals, we utilized the GBD standard life table created by selecting the lowest observed death rate for any age group in countries of more than 5 million in population [21]. This choice of a life expectancy standard is a values-based decision, in that it counts the “value” of all deaths worldwide the same regardless of nation or sex.

Because life expectancy differs by country and over time, we conducted a sensitivity analysis by estimating DALYs based on Iraqi life expectancy using World Bank estimates. In 2013, life expectancy at birth for Iraq was 69.4 years [22]. Methods did not otherwise differ from those used for calculations using the GBD life table.

Analysis plan

The analysis was planned to utilize previously published GBD methods adapted to calculate incidental DALYs from an existing conflict data set. However, these calculations offered ample opportunity for error, and, therefore, to mitigate the possibility of error while applying our analysis, we selected at random a single patient with each injury pattern and performed the calculations by hand to ensure accurate calculations following complete analysis of the data (S1 Analysis Plan). Once these calculations were performed to determine the “correct” answer for each injury pattern, the methods for bootstrapping and variation of DWs with each repetition were developed later after complete data cleaning. However, as our work focuses primarily on the proposed methods for these calculations no data driven changes to the analysis occurred.

Assessment of injury patterns and duration of disability

The calculation of DALYs from a specific data set requires aligning GBD methodology with data collection methods. YLDs require the use of differing DWs for differing injury patterns. The Baghdad injury data established 6 separate injury patterns, based on the key question (“Did the injured person suffer any disability that affects the ability to do normal activities for some days?”) and a follow-up question on the duration of disability (expressed in years, months, weeks, days, or continuing).

Calculation of YLLs

For individuals who died between 2003 and 2014, we recorded age at time of death. This age was compared to the GBD life table to determine the difference between age at injury and life expectancy. YLLs were calculated when a person died of a conflict-related intentional injury, an outcome recorded on data collection. For 3 individuals, death was deemed either unrelated to the injury or only possibly related to the injury. These individuals were not included in the YLL calculation but were instead included in YLD calculations for the documented duration of their disability. YLLs have an outsized effect on total DALY calculations; therefore, conservative practice required YLLs to be calculated only for individuals who definitively died of their injury.

Short-term injury

An injury was deemed to be “short term” when it persisted for less than 1 year [10]. Short-term injury DWs were used in the calculation of YLDs [23]. DALYs caused by short-term injury were calculated by multiplying the short-term injury DW for each patient by the duration of disability in fractions of years. Respondents reported the length of disability for short-term injury in months, weeks, or days. These values were divided by 12, 52, and 365, respectively, to create the fraction of the year used in the calculations.

Long-term injury with recovery, both treated and untreated

Individuals who sustained injuries from which they recovered, but resulted in disability lasting a year or longer, formed the second injury pattern. We asked where injured individuals received care at the time of injury (hospital, health clinic, place of employment, or no care). For those who received no treatment, we calculated the burden of injury by multiplying the duration of the disability by the matched untreated DW. Individuals receiving any post-injury care were matched to the appropriate DW for treated patients; all levels of care were considered equal for this analysis.

Long-term injury without recovery, both treated and untreated

Individuals who remained disabled at the time of data collection were classified as having permanent disability. We assumed these individuals would not have a shorter life expectancy but also would be unlikely to have a full recovery from their injuries. We also applied both treated and untreated DWs to these individuals. YLD calculations were made by multiplying treated and untreated DWs by the maximum life expectancy corresponding to the person’s age at the time they were injured.

Use of incidence versus prevalence DALYs

Readers familiar with the GBD methodology will note the calculations described here are based on the use of incidence, rather than prevalence YLDs. This represents the main deviation from the GBD methodology for application to a specific conflict data set. For the 2010 iteration of the GBD, the methodology was changed from using incidence-based YLDs to prevalence-based YLDs [10]. The reasoning for this change and the effects on the results are covered further in the discussion. YLLs remained incidence based, creating what some have referred to as a hybrid approach [24]. We initially performed calculations with incidence YLDs; however, we also calculated prevalence YLDs for comparison.

Bootstrapping

Burden of disease estimates have an inherent degree of uncertainty that arises from data collection, adjustments to the data, and statistical models. We would argue that the very nature of quantifying the burden of an individual’s health state is also subject to some degree of uncertainty as an injury of both the same cause and nature may “burden” 2 individual patients to different degrees. Therefore, in accordance with GBD methods, uncertainty was propagated through the data set by repeating each calculation 1,000 times, with each drawing from the 1,000 draw distributions around each individual DW code.

Following data cleaning, 225 individuals remained who sustained a conflict-related intentional injury between 2003 and 2014. For purposes of matching DWs, we had sufficient information on 179 cases. To calculate YLD, we required either age at the time of injury for those injuries without recovery or the duration of disability from the injury for those injuries with recovery. Additionally, we needed to determine whether care was delivered. These 179 cases were resampled with replacement to create 1,000 separate samples. A randomly selected set of matched DWs from the appropriate DW table was mapped to each sample. We did not vary the DWs for cause-specific calculations, as variation in the DWs would not alter the final total. Summary statistics were then calculated from these 1,000 iterations. For cause-specific estimates, sampling with replacement was performed.

A total of 46 individuals with conflict-related intentional injury could not be used in the calculation of DALYs for the sample due to missing data points. For 29 of these individuals, the age at time of injury and duration of injury were missing. The remaining 17 individuals without death due to injury lacked the necessary information to pair the injury of the patient with a proper DW. The only injury mechanism overrepresented in those individuals detailed above was burn injuries. Otherwise, no injury mechanism was overly affected by the exclusions listed above.

Extrapolation to the city of Baghdad

Following bootstrapping, we obtained the mean number of DALYs in the sample and divided this by the total number individuals that were sampled with replacement. We then multiplied the mean of the total DALYs by Baghdad population estimates. This was repeated for the lower and upper ends of the uncertainty interval (UI). Cause-specific DALY counts were generated in a similar fashion.

Analysis

All analysis and data manipulation were performed using the R language for statistical computing [25]. We have provided the code and data set as a supplement (S1 Data Dictionary and R Code Publication and S1 DALY Data). This study is reported as per the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guideline (S1 STROBE Guidelines Checklist) [26].

Ethical approval

Ethical approval for the study was obtained from Mustansiriya University’s scientific committee, and survey permission from the city of Baghdad. For security reasons, only verbal consent was obtained, with informed consent by participants recorded by the interviewers. Interviews were conducted privately. The Institutional Review Boards of Johns Hopkins and the University of Washington determined the analysis of deidentified data as not human participant research.

Results

Approximately 900 households were visited, and information was collected on 5,148 persons. This encompassed individuals who were living and those who had died from their injuries. The average household size was 5.72. The age breakdown of participants was as follows: 12% (n = 607) were under the age of 5, 44.2% (n = 2,274) were under 19, and 7.2% (n = 368) were over age 60. Household composition was evenly divided between males and females [11].

The initial sample contained 5,148 individuals, of whom 225 (4.4%) suffered conflict-related injuries between 2003 and 2014. Of these individuals, 88 died as a result of their injury, and 137 had injuries resulting in some degree of disability. Approximately 20% of these were excluded due to missing data required for the bootstrap analysis, leaving a final sample of 179 Baghdad household members sampled who were either injured or died due to conflict-related intentional injury.

We estimated 4,160 DALYs (95% UI 3,180 to 5,090) were lost due to conflict-related intentional injuries between 2003 and early 2014 among our surveyed respondents using standard life tables. Participants with conflict-related intentional injuries suffered an average 22 lost DALYs per injury (95% UI 19.5 to 26.9) or 0.81 (95% UI 0.51 to 1.12) per person. We estimated 3,700 YLLs overall (95% UI 2,800 to 4,500) or a mean 42 YLLs per death (95% UI 33 to 52). The mean number of YLLs for the sample was 0.72 per person (95% UI 0.54 to 0.87).

Among our respondents and their households, we estimated 450 YLDs (95% UI 296 to 663) resulting from conflict-related intentional injuries during the study period. The mean number of YLDs for the sample was 0.09 per person (95% UI 0.03 to 0.15) or 3.7 mean YLDs attributable to each injury (95% UI 2.4 to 5.3).

By multiplying our survey population rates by the total city population, we calculated a total municipal burden of conflict-related intentional injury. Because the initial survey clusters were assigned using PPES techniques, no post-survey weighting adjustments were required. The population of Baghdad at the time of data collection was estimated to be 6.90 million [27]. We estimate, therefore, 5.60 million DALYs (95% UI 4.30 million to 6.90 million) are owed to conflict-related intentional injuries between 2003 and early 2014 in the city of Baghdad. The burden of mortality in Baghdad from conflict-related intentional injury was 4.99 million YLLs (95% UI 3.87 million to 6.13 million). The estimated burden of injury for the city was 616,000 YLDs (95% UI 399,000 to 894,000) if calculated with incidence YLDs. The year-by-year estimates by DALYs, YLLs, and YLDs for the city of Baghdad are summarized in Fig 1.

Fig 1. Burden of conflict-related intentional injury by year in Baghdad, Iraq, 2003–2014, portraying total DALYs, as well as contributions of YLLs and YLDs.

Fig 1

Source of data: survey of 900 Baghdad residents in May and June 2014, regarding household injury events between 2003 and 2014. DALY, disability-adjusted life year; YLD, year lived with disability; YLL, year of life lost.

For comparison, we performed the same calculation for conflict-related intentional injuries utilizing an Iraq-specific life expectancy. We estimate that 4,010 DALYs (95% UI 3,070 to 49,700) were lost from within the study sample. When extrapolated to the city of Baghdad as a whole, we estimate 5.41 million DALYs lost attributable to conflict-related intentional injuries (95% UI 4.14 million to 6.70 million).

As stated previously by our proposed method of calculation, we would estimate 450 incidence YLDs (95% UI 296 to 663) lost by the study population from 2003 to 2014. We repeated this calculation utilizing prevalence YLDs, counting them only for the time between the time of injury and the end of the study time frame. This resulted in a total of 49.7 prevalence YLDs (95% UI 31 to 72) lost over the course of the study. The year-by-year estimates of YLDs calculated by both incidence and prevalence techniques are summarized in Fig 2.

Fig 2. Comparison of incidence-based and prevalence-based YLDs in Baghdad, Iraq, from 2003–2014.

Fig 2

Source of data: survey of 900 Baghdad residents in May and June 2014, regarding household injury events between 2003 and 2014. YLD, year lived with disability.

Table 1 and Fig 3 portray the 7 causes of conflict-related intentional injury identified. Only one case of death by torture was named (accounting for 58 DALYs lost), although additional cases may have been missed because of a reluctance to report. Gunshot wounds made up the majority (57%) of all DALYs. Approximately 10% of the sample DALYs were attributable to blasts and explosions, with shelling and unspecified mechanisms accounting for 16% and 14%, respectively.

Table 1. Proportion of DALYs by cause, total DALYs by cause for the sample, and estimated DALYs for the population of Baghdad, Iraq, with 95% UI.

Injuries-specific mechanism Proportion of DALYs Sample total DALYs Population estimate DALYs 95% UI (DALYs)
Gunshots 56.8% 2,348 3,166,000 2,277,000–4,175,000
Shelling 16.0% 662 893,000 460,000–1,396,000
Other 14.4% 596 803,000 372,000–1,276,000
Blasts and explosions 9.7% 401 540,000 227,000–912,000
Stabbing 1.5% 61 82,000 17–248,000
Burns 1.7% 70 93,800 0–286,000

Source of data: survey of 900 Baghdad residents in May and June 2014, regarding household injury events between 2003 and 2014.

DALY, disability-adjusted life year; UI, uncertainty interval.

Fig 3. DALYs lost to each identified cause of intentional injury in Baghdad, Iraq, 2003–2014.

Fig 3

Source of data: survey of 900 Baghdad residents in May and June 2014, regarding household injury events between 2003 and 2014. DALY, disability-adjusted life year.

Discussion

We estimate 5.6 million human DALYs were lost among residents of the city of Baghdad as a result of conflict-related intentional injuries over the course of the US-led coalition invasion of Iraq and subsequent insurgency. Our aim was to demonstrate a statistical method for describing the cumulative effects of both lives lost and years of disability generated by a conflict on a population to allow comparisons among future conflicts.

Because of the, to our knowledge, novelty of this method of calculation and its application to a conflict-specific data set, it is difficult to compare our results with other settings. We did find a study from South Africa where a team used local data combined with GBD techniques to provide an estimate of DALYs lost attributable to interpersonal violence. Matzopoulos and colleagues calculated that an estimated 2,605 DALYs per 100,000 population were lost to homicide and other interpersonal violence in South Africa [28]. By our estimates, Baghdad lost 5,320 DALYs per 100,000 population in 2008 and 1,390 DALYs per 100,000 population during 2012, the highest and lowest burden of injury years in our data set. These comparisons should be made cautiously, however, as the South Africa data relied on modeling to fill in some data gaps and used a hybrid DALY approach, whereas we used an incidence-based DALY approach.

Our statistical techniques for estimating mechanisms of injury generated wide UIs, as noted in Table 1. As the analysis is applied to fewer and fewer individuals within the sample, when sampling a specific cause of injury, the likelihood that all injury patterns will be represented in each sample decreased, resulting in broadened UIs. Our confidence in the results, however, was increased with the finding that gunshot wounds comprised more than half the DALYs lost within the study, consistent with previous research on mechanisms of death in the Iraq War [7].

The goal of all conflict epidemiology is to better understand the health burden of conflict at a population level. Our study demonstrates how to apply these methods originally developed to measure the burden of diseases to the effects of conflict. In applying these methods to our previously published cause-specific estimates in Baghdad, we hope to capture both the cumulative burden of mortality and injury on the population, as well as demonstrate how our methods can be applied to other conflicts or populations. We believe these methods can provide a more complete picture of the burden of conflict on a population than previous methods. Our previous works have described the effect of conflict-related intentional injuries in Baghdad in terms of injuries per 1,000 years of exposure (5.0 95% CI 4.3 to 5.6) [11]. We also expressed the toll of conflict for the nation as a whole as being 4.55 deaths per 1,000 person-years (95% UI 3.74 to 5.27). While these other figures represent accepted methods for describing the health effects of conflict on a population, we developed this methodology to provide a picture of both the morbidity and mortality of a conflict with a single method and cumulative measurement.

These results demonstrate the importance of epidemiologically sound assessment of conflicts. Media reports tend to focus heavily on the more “spectacular” aspects of conflict, such as explosions, shelling, and air strikes. Passive methods of data collection, such as the Iraq Body Count, significantly underestimate the burden of injury—in this case possibly by a 3-fold undercount [9]. Both the number of injuries and total burden of injury suggest that the majority of morbidity and mortality was attributable to small arms rather than blasts or explosions. This is in line with many of the population-based surveys that identified gunshot wounds as the most common cause of death [8,10]. Even if shelling is included along with blasts and explosions, results suggest a 2-fold underestimation of the burden of conflict-related intentional injury, highlighting the importance of survey techniques such as random household surveys.

The large difference in incidence YLDs and prevalence YLDs (450 incidence YLDs versus 49.7 prevalence YLDs for the study population) is best illustrated by focusing on young individuals who sustain a lifelong disability. Using our proposed incident-based approach, a 20-year-old man who sustains a lifelong disability in 2011 (with an example DW of 0.2) would have 67 YLDs. We would allocate the entirety of his YLDs from his injury (i.e., approximately 67 years × 0.2) to a single year (2011). Using the prevalence YLD approach, 0.2 would be added to each year (i.e., 2012, 2013…) for the remainder of the anticipated life expectancy at the time of the person’s injury. Both of these methods result in a total of approximately 13.4 YLDs; however, under an incident-based approach, all are allocated in 2011, while for a prevalence-based approach, 0.2 are allocated each year for the remainder of the individual’s life.

Calculations were performed using both incidence- and prevalence-based YLDs. Prevalence YLDs are relatively stable over time and allow long-term comparison of the burden of disease among countries and are used for the current GBD studies. We concluded that incidence-based YLDs would be more helpful in understanding a time-specific conflict, because they better highlight the ebbs and flows of a conflict [24]. More specifically, we posit that the calculation of purely incidence-based DALYs provides a better picture of the long-term effects of a specific set of events on a given population. Other investigators may propose a prevalence-based approach to calculating the burden of injury for a conflict, but we believe that approach fails to capture the speed at which modern conflicts change and evolve. For the purpose of creating a burden of disease estimate for modern, dynamic conflicts, we propose researchers use an incidence-based approach.

We were fortunate to complete the survey weeks before conditions on the ground deteriorated to the point where data collection would have been impossible. In June of 2014, the Islamic State of Iraq and Syria (ISIS) began a major offensive, resulting in the fall of Mosul and Tikrit [29].

Our participants were drawn from a population-proportionate sample of the city of Baghdad, so no adjustments were required following analysis. We did not adjust for changes in population over the course of the study, and citywide estimates were not weighted by administrative unit.

Survey participants asked to recall serious injuries in their households dating to 2003 may have failed to remember events more than a decade ago or lost members in a position to report on such events. Mock and colleagues reported on a household survey of injuries in a non-conflict area (Ghana), finding a significant rate of decline in recall after 1 month [30]. However, the same study showed that for injuries resulting in more than 30 days of disability, there was a minimal decline in recall. Any recall bias, however, only serves to make our estimates more conservative underestimates for the true burden.

Our methods present several opportunities for underestimation of the total burden of injury for this population. First, any individuals not definitively identified as having died of their injuries by the survey were calculated as YLDs rather than YLLs, and their contribution to the total would be significantly undervalued. However, by making assumptions regarding individuals who likely died of their injuries but were not definitively identified as having done so, we ran a significant risk of inflating our results in the opposite direction. Recall bias also presents a risk of undervaluing the contribution of YLDs to the total as people are less likely to forget a death than an injury. An additional aspect of recall bias is that lay reporting of certain injuries (i.e., by nonmedical professionals) might lead to certain types of injuries being remembered better than others (i.e., long bone fractures might be more memorable than soft tissue injuries). Injuries and death resulting from self-harm were also not counted as we elected to focus on injuries that directly resulted from conflict rather than its secondary effects; however, a case can certainly be made that these events should be considered in future analyses to fully capture the effects of conflict on a society. Last, we extrapolated to the population of Baghdad by multiplying the mean DALYs, YLLs, and YLDs by the population of the city. The mean numbers were achieved after bootstrapping, but this is a source for underestimation as individuals excluded from the study for lack of sufficient data to perform calculations may have increased the mean per person if included. However, it is unlikely that the inclusion of these individuals would have altered the UIs for the study. It is also possible that some households were selective in their reports to the survey teams regarding either the duration or circumstances of deaths or injuries within their households.

Public health researchers attempt assessments of the consequences of conflict in hopes of finding opportunities for primary, secondary, and tertiary prevention of population health disasters. Our contribution to conflict epidemiology goes beyond previous reports of simple crude mortality to assess long-term population health by calculating YLLs (or rendered disabled) by conflict-related intentional injuries. We include only estimates of the conflict-related intentional injuries suffered by the population of Baghdad, without consideration of unintentional injuries or downstream effects of conflict. The total burden of injury from all causes during this time frame, therefore, is certainly higher than our estimates—and it could be argued some of these, while not intentional, were otherwise conflict related.

With more sophisticated analyses, epidemiologists might better predict losses in advance of the onset of conflict, as well as assist civilian and military health systems in planning for care delivery. It could allow policy makers to better judge the health effects of various phases of the conflict in relation to military strategy. The US Army and Marine Corps Counterinsurgency Field Manual recommends, “whatever else is done, the focus must remain on gaining and maintaining the support of the population [31].” Public health efforts to better understand the effects of war on local populations would allow improved pursuit of that mission.

Findings from this study provide additional understanding of the population health effects of the Iraq War. Further study of this conflict is important given the paucity of data on the effects of urban warfare with high-velocity weapons on local populations. Future researchers may develop more sophisticated methods for addressing recall bias in long-running conflicts, as well as identify methods of accounting for the hazards of missing households who have been displaced or migrated. More sophisticated methods might also ensure the capture of all data points required for the calculation of disability-adjusted measures. When calculating DALYs, researchers may also weigh the benefits of incidence versus prevalence YLDs, based on the specific question being asked. To the best of our knowledge, ours may be the first attempt to directly assess DALYs lost in relation to injuries and disabilities caused by a war; our hope was to contribute to improved epidemiologic methods to expand the understanding of the health effects of war.

Disclaimer

The views expressed in this paper are those of the authors and do not reflect the official policy or position of the Department of the Navy, Department of Defense, or the US Government.

Supporting information

S1 STROBE Guidelines Checklist. Completed Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines checklist applicable to this work.

(PDF)

S1 Analysis Plan. Prospective analysis plan for calculation of DALYs for all injury patterns.

(PDF)

S1 Data Dictionary and R code Publication. Definitions of terms contained in shared data set, R code for bootstrapped calculation of incidence based DALYs, and definition of terms contained within the function.

(PDF)

S1 Questionnaire. English version of the survey tool designed and utilized for household survey and data collection by Lafta and colleagues during initial data collection.

(PDF)

S1 DALY Data. Shared data set needed for replication of this work.

The data are provided in the csv file format.

(CSV)

Abbreviations

DALY

disability-adjusted life year

DW

disability weight

GBD

Global Burden of Disease

PPES

probability proportional to estimated size

UI

uncertainty interval

YLD

year lived with disability

YLL

year of life lost

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

This work was supported by Surgeons OverSeas, http://www.surgeonsoverseas.org/. RL received the funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The first author’s work (GJ) on this project was supported in part by the National Center for Advancing Translational Sciences, National Institutes of Health, through grant number UL1 TR001860. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funder had no role in study design, data collection, decision to publish or preparation of the manuscript.

References

  • 1.Levy BS, Sidel VW. Documenting the Effects of Armed Conflict on Population Health. Ann Rev Public Health. 2016;37:205–18. doi: 10.1146/annurev-publhealth-032315-021913 [DOI] [PubMed] [Google Scholar]
  • 2.Murray CJ, King G, Lopez AD, Tomijima N, Krug EG. Armed conflict as a public health problem. BMJ. 2002;324(7333):346–9. doi: 10.1136/bmj.324.7333.346 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Burnham G, Malik S, Dhari Al-Shibli AS, Mahjoub AR, Baqer AaQ, Baqer ZQ, et al. Understanding the impact of conflict on health services in Iraq: information from 401 Iraqi refugee doctors in Jordan. Int J Health Plann Manage. 2012;27(1):e51–e64. doi: 10.1002/hpm.1091 [DOI] [PubMed] [Google Scholar]
  • 4.Donaldson RI, Hung YW, Shanovich P, Hasoon T, Evans G. Injury burden during an insurgency: the untold trauma of infrastructure breakdown in Baghdad, Iraq. J Trauma Acute Care Surg. 2010;69(6):1379–85. doi: 10.1097/TA.0b013e318203190f [DOI] [PubMed] [Google Scholar]
  • 5.Garfield R. Challenges to health service development in Iraq. Lancet. 2003;362(9392):1324. Epub 2003/10/29. doi: 10.1016/S0140-6736(03)14578-3. [DOI] [PubMed] [Google Scholar]
  • 6.Group IFHSS. Violence-related mortality in Iraq from 2002 to 2006. N Engl J Med. 2008(358):484–93. doi: 10.1056/NEJMsa0707782 [DOI] [PubMed] [Google Scholar]
  • 7.Hagopian A, Flaxman AD, Takaro TK, Esa Al Shatari SA, Rajaratnam J, Becker S, et al. Mortality in Iraq associated with the 2003–2011 war and occupation: findings from a national cluster sample survey by the university collaborative Iraq Mortality Study. PLoS Med. 2013;10(10):e1001533. doi: 10.1371/journal.pmed.1001533. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Roberts L, Lafta R, Garfield R, Khudhairi J, Burnham G. Mortality before and after the 2003 invasion of Iraq: cluster sample survey. Lancet. 2004;364(9448):1857–64. doi: 10.1016/S0140-6736(04)17441-2 [DOI] [PubMed] [Google Scholar]
  • 9.Tapp C, Burkle FM, Wilson K, Takaro T, Guyatt GH, Amad H, et al. Iraq War mortality estimates: a systematic review. Confl Health. 2008;2(1):1. doi: 10.1186/1752-1505-2-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Haagsma JA, Graetz N, Bolliger I, Naghavi M, Higashi H, Mullany EC, et al. The global burden of injury: incidence, mortality, disability-adjusted life years and time trends from the Global Burden of Disease study 2013. Inj Prev. 2016Feb1;22(1):3–18. doi: 10.1136/injuryprev-2015-041616 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Lafta R, Al-Shatari S, Cherewick M, Galway L, Mock C, Hagopian A, et al. Injuries, death, and disability associated with 11 years of conflict in Baghdad, Iraq: a randomized household cluster survey. PloS ONE. 2015;10(8):e0131834. doi: 10.1371/journal.pone.0131834 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Stewart BT, Lafta R, Al Shatari SAE, Cherewick M, Burnham G, Hagopian A, et al. Burns in Baghdad from 2003 to 2014: Results of a randomized household cluster survey. Burns. 2016Feb1;42(1):48–55. doi: 10.1016/j.burns.2015.10.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Stewart BT, Lafta R, Al Shatari SAE, Cherewick M, Flaxman A, Hagopian A, et al. Fall injuries in Baghdad from 2003 to 2014: results of a randomised household cluster survey. Injury. 2016;47(1):244–9. doi: 10.1016/j.injury.2015.11.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Stewart BT, Lafta R, Cherewick M, Al Shatari SAE, Flaxman AD, Hagopian A, et al. Road traffic injuries in Baghdad from 2003 to 2014: results of a randomised household cluster survey. Inj Prev. 2016Oct1;22(5):321–7. doi: 10.1136/injuryprev-2015-041707 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Mock CN, Abantanga F, Cummings P, Koepsell TD. Incidence and outcome of injury in Ghana: a community-based survey. Bull World Health Organ. 1999;77(12):955. [PMC free article] [PubMed] [Google Scholar]
  • 16.Petroze RT, Joharifard S, Groen RS, Niyonkuru F, Ntaganda E, Kushner AL, et al. Injury, disability and access to care in Rwanda: results of a nationwide cross-sectional population study. World J Surg. 2015;39(1):62–9. doi: 10.1007/s00268-014-2544-9 [DOI] [PubMed] [Google Scholar]
  • 17.Stewart K-AA, Groen RS, Kamara TB, Farahzad MM, Samai M, Cassidy LD, et al. Traumatic injuries in developing countries: report from a nationwide cross-sectional survey of Sierra Leone. JAMA Surg. 2013;148(5):463–9. doi: 10.1001/jamasurg.2013.1341 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Galway L, Bell N, Sae AS, Hagopian A, Burnham G, Flaxman A, et al. A two-stage cluster sampling method using gridded population data, a GIS, and Google Earth(TM) imagery in a population-based mortality survey in Iraq. Int J Health Geogr. 2012Dec;11(1):1–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Salomon JA, Vos T, Hogan DR, Gagnon M, Naghavi M, Mokdad A, et al. Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet. 2013;380(9859):2129–43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2013;380(9859):2197–223. [DOI] [PubMed] [Google Scholar]
  • 21.Murray CJ, Ezzati M, Flaxman AD, Lim S, Lozano R, Michaud C, et al. GBD 2010: design, definitions, and metrics. Lancet. 2012;380(9859):2063–6. doi: 10.1016/S0140-6736(12)61899-6 [DOI] [PubMed] [Google Scholar]
  • 22.World Bank Country Data. Iraq Online: World Bank; 2016 [cited 2017 Jan 7].
  • 23.Salomon JA, Haagsma JA, Davis A, de Noordhout CM, Polinder S, Havelaar AH, et al. Disability weights for the Global Burden of Disease 2013 study. Lancet Glob Health. 2015;3(11):e712–e23. doi: 10.1016/S2214-109X(15)00069-8 [DOI] [PubMed] [Google Scholar]
  • 24.Schroeder SA. Incidence, prevalence, and hybrid approaches to calculating disability-adjusted life years. Popul Health Metr. 2012;10(1):19. doi: 10.1186/1478-7954-10-19 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.R Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing. 2013. [Google Scholar]
  • 26.Von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med. 2007;147(8):573–7. doi: 10.7326/0003-4819-147-8-200710160-00010 [DOI] [PubMed] [Google Scholar]
  • 27.Lafta R, Al-Shatari S, Cherewick M, Galway L, Mock C, Hagopian A, et al. Data from: Injuries, death, and disability associated with 11 years of conflict in Baghdad, Iraq: a randomized household cluster survey. Dryad Data Repository; 2015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Matzopoulos R, Norman R, Bradshaw D. The burden of injury in South Africa: Fatal injury trends and international comparisons. Tygerberg: Medical Research Council-University of South Africa, Crime, Violence and Injury Lead Programme; 2004. [Google Scholar]
  • 29.The Wilson Center. Timeline: The Rise, Spread, and Fall of the Islamic State. Available from: https://www.wilsoncenter.org/article/timeline-the-rise-spread-and-fall-the-islamic-state: 28 October 2019.
  • 30.Mock C, Acheampong F, Adjei S, Koepsell T. The effect of recall on estimation of incidence rates for injury in Ghana. Int J Epidemiol. 1999;28(4):750–5. doi: 10.1093/ije/28.4.750 [DOI] [PubMed] [Google Scholar]
  • 31.Gentile GP. A Strategy of Tactics: Population-centric COIN and the Army. Parameters. 2011;41(4):1. [Google Scholar]

Decision Letter 0

Artur Arikainen

8 Jun 2020

Dear Dr Jensen,

Thank you for submitting your manuscript entitled "Calculating the burden of intentional injuries and disabilities in Baghdad, 2003-2014" for consideration by PLOS Medicine.

Your manuscript has now been evaluated by the PLOS Medicine editorial staff and I am writing to let you know that we would like to send your submission out for external peer review.

However, before we can send your manuscript to reviewers, we need you to complete your submission by providing the metadata that is required for full assessment. To this end, please login to Editorial Manager where you will find the paper in the 'Submissions Needing Revisions' folder on your homepage. Please click 'Revise Submission' from the Action Links and complete all additional questions in the submission questionnaire.

Please re-submit your manuscript within two working days, i.e. by .

Login to Editorial Manager here: https://www.editorialmanager.com/pmedicine

Once your full submission is complete, your paper will undergo a series of checks in preparation for peer review. Once your manuscript has passed all checks it will be sent out for review.

Feel free to email us at plosmedicine@plos.org if you have any queries relating to your submission.

Kind regards,

Artur Arikainen,

Associate Editor

PLOS Medicine

Decision Letter 1

Emma Veitch

10 Jul 2020

Dear Dr. Jensen,

Thank you very much for submitting your manuscript "Calculating the burden of intentional injuries and disabilities in Baghdad, 2003-2014" (PMEDICINE-D-20-02532R1) for consideration at PLOS Medicine.

Your paper was evaluated by a senior editor and discussed among all the editors here, as well as being evaluated by three independent reviewers, including a statistical reviewer. The reviews are appended at the bottom of this email and any accompanying reviewer attachments can be seen via the link below:

[LINK]

In light of these reviews, I am afraid that we will not be able to accept the manuscript for publication in the journal in its current form, but we would like to consider a revised version that addresses the reviewers' and editors' comments. Obviously we cannot make any decision about publication until we have seen the revised manuscript and your response, and we plan to seek re-review by one or more of the reviewers.

In revising the manuscript for further consideration, your revisions should address the specific points made by each reviewer and the editors. Please also check the guidelines for revised papers at http://journals.plos.org/plosmedicine/s/revising-your-manuscript for any that apply to your paper. In your rebuttal letter you should indicate your response to the reviewers' and editors' comments, the changes you have made in the manuscript, and include either an excerpt of the revised text or the location (eg: page and line number) where each change can be found. Please submit a clean version of the paper as the main article file; a version with changes marked should be uploaded as a marked up manuscript.

In addition, we request that you upload any figures associated with your paper as individual TIF or EPS files with 300dpi resolution at resubmission; please read our figure guidelines for more information on our requirements: http://journals.plos.org/plosmedicine/s/figures. While revising your submission, please upload your figure files to the PACE digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at PLOSMedicine@plos.org.

We expect to receive your revised manuscript by Jul 31 2020 11:59PM. Please email us (plosmedicine@plos.org) if you have any questions or concerns.

***Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.***

We ask every co-author listed on the manuscript to fill in a contributing author statement, making sure to declare all competing interests. If any of the co-authors have not filled in the statement, we will remind them to do so when the paper is revised. If all statements are not completed in a timely fashion this could hold up the re-review process. If new competing interests are declared later in the revision process, this may also hold up the submission. Should there be a problem getting one of your co-authors to fill in a statement we will be in contact. YOU MUST NOT ADD OR REMOVE AUTHORS UNLESS YOU HAVE ALERTED THE EDITOR HANDLING THE MANUSCRIPT TO THE CHANGE AND THEY SPECIFICALLY HAVE AGREED TO IT. You can see our competing interests policy here: http://journals.plos.org/plosmedicine/s/competing-interests.

Please use the following link to submit the revised manuscript:

https://www.editorialmanager.com/pmedicine/

Your article can be found in the "Submissions Needing Revision" folder.

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see http://journals.plos.org/plosmedicine/s/submission-guidelines#loc-methods.

Please ensure that the paper adheres to the PLOS Data Availability Policy (see http://journals.plos.org/plosmedicine/s/data-availability), which requires that all data underlying the study's findings be provided in a repository or as Supporting Information. For data residing with a third party, authors are required to provide instructions with contact information for obtaining the data. PLOS journals do not allow statements supported by "data not shown" or "unpublished results." For such statements, authors must provide supporting data or cite public sources that include it.

We look forward to receiving your revised manuscript.

Sincerely,

Emma Veitch, PhD

PLOS Medicine

On behalf of Clare Stone, PhD, Acting Chief Editor,

PLOS Medicine

plosmedicine.org

-----------------------------------------------------------

Requests from the editors:

*We'd suggest revising the title according to PLOS Medicine's style, ideally this should include some indication of the study design as part of the title after a colon (eg, XXYY: "A randomized controlled trial," "A retrospective study," "A modelling study," etc.)

*Please structure the abstract using the PLOS Medicine headings (Background, Methods and Findings, Conclusions - "Methods and Findings" is a single subsection).

*In the last sentence of the Abstract Methods and Findings section, please describe the main limitation(s) of the study's methodology.

*At this stage, we ask that you include a short, non-technical Author Summary of your research to make findings accessible to a wide audience that includes both scientists and non-scientists. The Author Summary should immediately follow the Abstract in your revised manuscript. This text is subject to editorial change and should be distinct from the scientific abstract. Please see our author guidelines for more information: https://journals.plos.org/plosmedicine/s/revising-your-manuscript#loc-author-summary

*We'd suggest revising the quantitative estimates in the abstract so these are clearer and relate more precisely to the estimates given in the main text, ie an point estimate (of central tendency) with uncertainty intervals/confidence intervals.

*Ideally, please update the in-text citation callout format (this should be sequential numerals in square brackets - ie [1], [2] etc) - if using referencing software this should be fairly quick and easy.

*Please clarify in the paper if the analytical approach used here corresponded to one laid out in a prospective protocol or analysis plan. Please state this (either way) early in the Methods section.

a) If a prospective analysis plan (from your funding proposal, IRB or other ethics committee submission, study protocol, or other planning document written before analyzing the data) was used in designing the study, please include the relevant prospectively written document with your revised manuscript as a Supporting Information file to be published alongside your study, and cite it in the Methods section. A legend for this file should be included at the end of your manuscript.

b) If no such document exists, please make sure that the Methods section transparently describes when analyses were planned, and when/why any data-driven changes to analyses took place.

c) In either case, changes in the analysis-- including those made in response to peer review comments-- should be identified as such in the Methods section of the paper, with rationale.

-----------------------------------------------------------

Comments from the reviewers:

Reviewer #1: I confine my remarks to statistical aspects of this paper. The general approach is fine, but I have some issues to resolve before I can recommend publication.

It would be better to calculate life expectancy at time of injury or death. The authors use either a world wide figure or one specific to Iraqis, but both of those are calculated at birth. The life expectancy of an adult is longer than the life expectancy at birth minus current age. If this can't be done here, some mention should be made of why not.

p. 4 Choosing 86 years for life expectancy seems wrong. I think the Iraqi figure used in the sensitivity analysis should be used in the main analysis. (But see above).

p, 5 The two assumptions in the first paragraph both seem dubious.

I commend the authors for using bootstrapping and for making their code available

Were there any differences between the 179 respondents and teh 46 who refused?

Peter Flom

-----------------------------------------------------------

Reviewer #2: Big picture thoughts:

It is stunning that outright deaths constituted the vast majority of years lost. This will be surprising to many and is important for thinking about the costs of conflict and in future eras the costs of reparations.

It is rare that a second analysis of a survey contributes something new and important, this is an exception.

There is a strong tendency for DALY analyses to come from large (e.g. DHS, MICS) datasets that were collected for some other purpose. This is a great example for a dataset collected for exactly this purpose (in this case, the burden of intentional injuries).

My one big criticism is that the discussion and conclusions read like an advertisement for DALY-type analyses but the results argue the opposite. A simple mortality survey is much easier to do than this complicated interview, asking the researchers to make difficult medical assessments (thus all interviewers were physicians) and bootstrap analyses. A simple mortality survey is closer to the cause of the problem in terms of the causal pathway. A simple mortality survey will likely have more political effect, be easier for the layperson to understand, and is closer in time and mechanism to all accountability processes like an ICC trial. If 90% of burden came directly from death, this study screams that we should focus on getting local professionals to focus on the easier more influential method. The issue is, perhaps with the Uyghurs, or the Rohingya, or other crises the Baghdad experience is not the norm. Exploring that in other settings seems to me the important value of this technique at this moment in history.

Small thoughts:

Methods

Rare and great that the interviewers where physicians.

"Because life expectancy represents the aspirational healthy life span for all individuals, we followed the GBD methodology of selecting the lowest observed death rate for any age group in countries of more than 5 million in population, or 86 years.22" While this might be referenced, it is so profound that it beckons a line or two more explaining what the reference in this case was (e.g. based on 140 countries across the globe or based on the 11 countries in the Middle-east over 5 million population or based on Baghdad in 2000 with some projection model?). Moreover there is a danger that future people will repeat this process in a completely different setting and the readers will not understand that difference will be because of the assumed life expectancy. Thus, it would be ideal if in the methods there could be a table of the male and female life expectancies at birth, 10, 20, 30, 40, 50, 60 ,70, 80, ...>85=0 or something like that.

YLLs have an outsized effect on total DALY calculations, therefore conservative practice required YLLs to be calculated only for individuals who definitively died of their injury." The implications of this are not covered in the discussion and should be.

Results

You say, "Forty-six individuals with intentional injury could not be used in the calculation of DALYs for the sample due to missing data points." So then is the denominator you used to assessing the burden of disease 5148 individuals, or some fraction of that population corrected for the incomplete data (e.g. 175/229 X 5148 would be one extreme while using 5148 as the denominator would be the other extreme)? Just ignoring those 46 with incomplete data would be markedly under-estimating the burden of injury and might be explaining why outright deaths are the lion's share of DALY's lost. Perhaps you did a sensitivity analysis (e.g. exclude vs. assume they had lost the average # DALY's as those with complete records....), but if so, I somehow missed it.

Discussion

"Both the number of injuries and total burden of injury suggest the majority of morbidity and mortality was attributable to small arms rather than blasts or explosions." Might be worth mentioning that the western press (as reflected by IBC and others) suggested explosions accounted for most violent deaths. This highlights the advantages of random HH surveys like this.

There are several mechanisms by which this is a likely under-estimate (if cause of death was blurry, excluding injuries where the data was not complete....) and this is not adequately addressed.

-----------------------------------------------------------

Reviewer #3: I read the revised version of the manuscript titled as "Calculating the burden of intentional injuries and disabilities in Baghdad, 2003-2014". The subject is important and interesting, but I think there are some issues in the manuscript.

Abstract

- "YLLs were calculated by subtracting the age at death from the age the subject might have expected to achieve at birth": This is not correct, and is not consistent with the Methods section in the full text. For calculating YLL, instead of life expectancy at birth, life expectancy at the age of death is used.

- I think "Finding" section of the abstract should include a little bit more of the important findings of the manuscript.

Methods

- Self-harm is not included in the study, so they cannot be considered equal to intentional injuries. It seems that the study covers include conflict and terrorism, as well as interpersonal violence. I think the whole manuscript should be checked for consistency.

- To calculate YLD, both external causes and nature of injuries should be available. It is not clear how a population survey is valid to extract frequency of different types of bodily injuries (nature of injury); non-medical professionals might remember injuries such as fracture in large bones, but usually are not capable to differentiate for instance a vascular injury from other soft tissue injuries. Also, there is a high probability of forgetting separate minor injuries or minor injuries in the context of a multiple trauma. Also, it is not clear how a cross-sectional survey can be used as a valid tool to estimate both prevalence and incidence during a relatively long period of time. I think it is necessary to explain a little more around the survey and validity of its data that have been used as the main source for this study.

- It is not clear how the number of fatalities has been estimated through such survey.

- The data are related to a specific period of time and cannot be updated (not sure why not published earlier), but is there any specific reason for authors preference on using GBD 2013 methodology (while GBD methods are continuously updated)

Findings

- It is better to provide some data on total number of deaths and injuries, before providing estimates for YLL, YLD and DALYs.

Discussion

- Is there any reason for the relatively huge difference between incidence-based and prevalence-based YLDs? Considering the fact that duration of disability is considered in calculations?

- There is no comparison with other studies; the estimated at least could be compared with the most recent GBD estimates for the same cause and same period of time

-----------------------------------------------------------

Any attachments provided with reviews can be seen via the following link:

[LINK]

Decision Letter 2

Artur Arikainen

5 Nov 2020

Dear Dr. Jensen,

Thank you very much for submitting your manuscript 'Calculating the burden of conflict-related intentional injuries and disabilities in Baghdad, 2003-2014: A modeling study and proposed method for calculating burden of injury in conflict' (PMEDICINE-D-20-02532R2) for consideration at PLOS Medicine.

Your article was also evaluated by our editorial team and one of the original independent reviewers from the earlier review round. Additionally, we received comments from a new reviewer, as one of the reviewers from the first round was unavailable to review the revised text. Please find their comments are pasted below.

[LINK]

We would like to consider a revised version that addresses the reviewers' and editors' comments. Please note that we cannot make any decision about publication until we have seen the revised manuscript and your response, and we may seek re-review by one or more of the reviewers.

In revising the manuscript for further consideration here, your revisions should address the specific points made by each reviewer and the editors. Please also check the guidelines for revised papers at http://journals.plos.org/plosmedicine/s/revising-your-manuscript for any that apply to your paper. In your rebuttal letter you should indicate your response to any comments from reviewers or editors and the changes you have made in the manuscript. Please submit a clean version of the paper as the main article file; a version with changes marked should be uploaded as a marked up manuscript.

In addition, we request that you upload any figures associated with your paper as individual TIF or EPS files with 300dpi resolution at resubmission; please read our figure guidelines for more information on our requirements: http://journals.plos.org/plosmedicine/s/figures.

While revising your submission, please upload your figure files to the PACE digital diagnostic tool, https://pace.apexcovantage.com/ PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at PLOSMedicine@plos.org.

We expect to receive your revised manuscript by . Please email us (plosmedicine@plos.org) if you have any questions or concerns.

We ask every co-author listed on the manuscript to fill in a contributing author statement, making sure to declare all competing interests. If any of the co-authors have not filled in the statement, we will remind them to do so when the paper is revised. If all statements are not completed in a timely fashion this could hold up the re-review process. If new competing interests are declared later in the revision process, this may also hold up the submission. Should there be a problem getting one of your co-authors to fill in a statement we will be in contact. YOU MUST NOT ADD OR REMOVE AUTHORS UNLESS YOU HAVE ALERTED THE EDITOR HANDLING THE MANUSCRIPT TO THE CHANGE AND THEY SPECIFICALLY HAVE AGREED TO IT. You can see our competing interests policy here: http://journals.plos.org/plosmedicine/s/competing-interests.

Please use the following link to submit the revised manuscript:

https://www.editorialmanager.com/pmedicine/

Your article can be found in the 'Submissions Needing Revision' folder.

We look forward to receiving your revised manuscript.

Sincerely,

Artur Arikainen,

Associate Editor

PLOS Medicine

plosmedicine.org

-----------------------------------------------------------

Requests from the editors:

1. Please address the reviewers’ comments below.

2. Please place the Author Summary after the Abstract.

3. Author Summary:

a. Please use the 3 standard PLOS Medicine subheadings listed here: https://journals.plos.org/plosmedicine/s/revising-your-manuscript#loc-author-summary.

b. Please use bullet points under the 3 subheadings.

c. Lines 43-44: Please rephrase this for clarity to a lay reader: “Previous researchers innovated the population-proportionate to size sampling methodology for household surveys in war zones…”

4. Abstract:

a. Please include summary participant/household demographics.

b. Line 87: Please define DALYs at first use.

5. Please move citations before punctuation, and remove spaces within the square brackets, eg: “…increasingly sophisticated [1,2].”

6. Line 293 Please mention if consent was “informed”.

7. Line 370: Please rename this section “Discussion”. Please present and organize the Discussion as follows: a short, clear summary of the article's findings; what the study adds to existing research and where and why the results may differ from previous research; strengths and limitations of the study; implications and next steps for research, clinical practice, and/or public policy; one-paragraph conclusion.

8. Please include the study questionnaires as Supporting Information files.

9. Please rename the analysis plan file ‘S1 Text’ and update the reference at line 197.

---

Comments from the reviewers:

Reviewer #1: The authors have addressed my concerns and I now recommend publication

Peter Flom

-

Reviewer #4: The paper focuses on measuring the impact of civil war using mortality as an indicator of severity. It proposes an alternative to previously used demographic approaches which calculated mortality rates based on data from household surveys. Here the authors still use household surveys but express the results in years of life lost or years lived with disability. They estimate about 4 - 6 million life years lost and 400 000 - 900 000 years lived with disability. Disability as the authors point out, is a persistent and socially significant problem especially among communities who have gone through a major conflict. The issue is also neglected and hence the paper is a welcome addition to the literature.

Previous reviews have raised detailed questions on the statistical aspects of the paper and the authors appear to have addressed them. I find two main weaknesses, which if handled, would strengthen this paper substantially.

First, the selected sampling units were extrapolated to whole of Baghdad. (line 281) This requires better explanation of how these units were selected and why the authors consider them representative of the city and therefore plausibly extrapolated to the whole city of about 7 million. Civil conflict, as is well known is an unpredictable affair in the ways it the action distributes itself. Areas of cities may remain untouched (e.g. Aleppo in the Syrian war) and some areas completely destroyed. The authors may have tested the sample for biases (a 5.5 household size in sample against 6.5 household size from the World Bank) but they do not present their work in the paper.

The section on Methods and findings begins with data collection without even a cursory description of the sampling design, household selection, construction of the sampling frame - all of which are foundational for what is to come - that is extrapolating the results from the 900 household. Why these 900 households are representative of the entire city population (about 7 million) is not explained despite being a critical pillar for the credibility of the final estimations (e.g. the sample in the study seems to have a family size of 5.5 although the family size I believe it's about 6.5 according to the World Bank. The section describes perhaps in disproportionate detail the YLL and YLD methods at the cost of explaining the sampling. The YLL and YLD methods are well known and could have been cited to the GBD documents. On the other hand, the sampling, its biases and the household selection underpins the very crux of this paper - extrapolation of the sample to the entire city and hence the final results.

Moreover the study applies standard YLL and YLD methods to data and that, per se, is not innovative. What maybe innovative is that this well-developed method is applied to Baghdad which had gone through a war. It may be a better idea to emphasize that aspect more than an innovation on the method.

Secondly, the results are a bit indecipherable since they don't make reference (Line 381 - 384) to anything else for the reader to compare - even YLL and YLDs made by GBD in poor countries without a conflict or indeed cities with an lot of urban violence such as Medellin or Lagos. What does 5.6 million DALYs mean in relation to other settings? It seems an huge number but is it? Or is this implausible. Some clarity on this would make the results much more relevant and understandable.

I am sure the authors are fully knowledgeable of all of these issues that I have described. Addressing them would strengthen the paper substantially.

---

Any attachments provided with reviews can be seen via the following link:

[LINK]

Decision Letter 3

Louise Gaynor-Brook

7 May 2021

Dear Dr. Jensen,

Thank you very much for re-submitting your manuscript "Calculating the burden of conflict-related intentional injuries and disabilities in Baghdad, 2003-2014: A modeling study and proposed method for calculating burden of injury in conflict" (PMEDICINE-D-20-02532R3) for review by PLOS Medicine.

I have discussed the paper with my colleagues and the academic editor. I am pleased to say that provided the remaining editorial and production issues are dealt with we are planning to accept the paper for publication in the journal.

The remaining issues that need to be addressed are listed at the end of this email. Any accompanying reviewer attachments can be seen via the link below. Please take these into account before resubmitting your manuscript:

[LINK]

***Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.***

In revising the manuscript for further consideration here, please ensure you address the specific points made by each reviewer and the editors. In your rebuttal letter you should indicate your response to the reviewers' and editors' comments and the changes you have made in the manuscript. Please submit a clean version of the paper as the main article file. A version with changes marked must also be uploaded as a marked up manuscript file.

Please also check the guidelines for revised papers at http://journals.plos.org/plosmedicine/s/revising-your-manuscript for any that apply to your paper. If you haven't already, we ask that you provide a short, non-technical Author Summary of your research to make findings accessible to a wide audience that includes both scientists and non-scientists. The Author Summary should immediately follow the Abstract in your revised manuscript. This text is subject to editorial change and should be distinct from the scientific abstract.

We expect to receive your revised manuscript within 1 week. Please email us (plosmedicine@plos.org) if you have any questions or concerns.

We ask every co-author listed on the manuscript to fill in a contributing author statement. If any of the co-authors have not filled in the statement, we will remind them to do so when the paper is revised. If all statements are not completed in a timely fashion this could hold up the re-review process. Should there be a problem getting one of your co-authors to fill in a statement we will be in contact. YOU MUST NOT ADD OR REMOVE AUTHORS UNLESS YOU HAVE ALERTED THE EDITOR HANDLING THE MANUSCRIPT TO THE CHANGE AND THEY SPECIFICALLY HAVE AGREED TO IT.

Please ensure that the paper adheres to the PLOS Data Availability Policy (see http://journals.plos.org/plosmedicine/s/data-availability), which requires that all data underlying the study's findings be provided in a repository or as Supporting Information. For data residing with a third party, authors are required to provide instructions with contact information for obtaining the data. PLOS journals do not allow statements supported by "data not shown" or "unpublished results." For such statements, authors must provide supporting data or cite public sources that include it.

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript.

Please note, when your manuscript is accepted, an uncorrected proof of your manuscript will be published online ahead of the final version, unless you've already opted out via the online submission form. If, for any reason, you do not want an earlier version of your manuscript published online or are unsure if you have already indicated as such, please let the journal staff know immediately at plosmedicine@plos.org.

If you have any questions in the meantime, please contact me or the journal staff on plosmedicine@plos.org.  

We look forward to receiving the revised manuscript by May 14 2021 11:59PM.   

Sincerely,

Louise Gaynor-Brook, MBBS PhD

Associate Editor 

PLOS Medicine

plosmedicine.org

------------------------------------------------------------

Comments from the Academic Editor:

The only additional suggestion to reinforce is one of the reviewers' requests to put these numbers (particularly injuries) in some context with previous work--is is a lot or not so many? The authors replied that this is difficult to do since their methods are different from past literature, however I think it would still be helpful to cite findings from from conflict situations that are broadly similar for context.

Requests from Editors:

General comments: Please try to address the comments by reviewers and the Academic Editor that some context/comparison for your findings would be helpful, in your revised text.

Please be consistent in the use of hyphenation of ‘conflict-related’ throughout the text

You have recorded in the submission form questionnaire that ‘My study does not require an ethics statement.’ If possible, please correct this to reflect the details of the ethical approval detailed in your methods section.

Title: Please revise your title according to PLOS Medicine's style. We suggest “Conflict-related intentional injuries and disabilities in Baghdad, Iraq, 2003-2014: A modeling study and proposed method for calculating burden of injury in conflict”

Abstract Background: Please expand upon why the study is important; what are the issues with using mortality as the primary measure of the population health effects of war?

Abstract Methods and Findings:

Please ensure to add that this is a modelling study.

Please provide brief demographic details on the population interviewed; gender, age, etc.

Please provide more detail on the data collected during interviews e.g. self-reported injury, ability to work, etc. which has contributed to your conclusions

Please move the paragraph beginning “”Our data come from interviews…” to the beginning of the Abstract Methods and Findings

Line 45 - Please consider rephrasing to “YLLs were calculated by subtracting the age at death from the expected age of death”. Please clarify what the expected age of death is based on.

Line 54 - please define UI at first use. Please revise 4.9 million to 4.99 million (as shown on line 59) if this is correct.

Line 59 - there is no need to repeat results; please omit “4.99 million YLLs lost (95% UI 3.87 million – 6.13 million) versus 616,000 YLDs lost (95% UI 60 399,000 – 894,000).”

Please begin your Abstract Conclusions with “"In this study, we calculated ..." or similar, to summarise your findings for the reader.

Author summary

Within ‘What Do These Findings Mean?’,

Please provide a non-technical summary of your results

Please include a final sentence outlining the limitations of your study

Please consider re-ordering the first two bullets points

Please rename ‘Background’ as ‘Introduction’

Line 115 - please omit sentence beginning ‘This paper reports a new approach…’

Methods

Please separate your ‘Methods and Findings’ section into separate ‘Methods’ and ‘Results’ sections

Please ensure that the study is reported according to the STROBE guideline, and include the completed STROBE checklist as Supporting Information. Please add the following statement, or similar, to the Methods: "This study is reported as per the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guideline (S1 Checklist)." The STROBE guideline can be found here: http://www.equator-network.org/reporting-guidelines/strobe/ When completing the checklist, please use section and paragraph numbers, rather than page numbers.

Please ensure that where methods are described elsewhere e.g. references 11 and 19, that the papers cited are open access. If not, please ensure to describe the methodology more thoroughly.

Please confirm whether the analysis plan was prospective

Line 237 - please omit ‘per Salomon’ (citation will suffice).

Line 314 - please quote the actual number/percentage of individuals excluded due to missing data in place of unspecific terms such as ‘nearly’

Discussion

Please remove subsection headings within the Discussion (e.g. Total DALYs Lost, and so on)

Please begin your Discussion with a short, clear summary of the article's findings.

Line 390 - please take note of the comments from the Academic Editor “to put these numbers (particularly injuries) in some context with previous work--is is a lot or not so many? [Although] methods are different from past literature… it would still be helpful to cite findings from from conflict situations that are broadly similar for context”.

Stylistically speaking, please add ‘to the best of our knowledge’ or similar to avoid assertions of primacy (e.g. "Because of the novelty of this research", “ours may be the first attempt…”)

References

Please ensure that references are appropriately formatted and journal titles are appropriately capitalised e.g. Annual Review of Public Health. Journal name abbreviations should be those found in the National Center for Biotechnology Information (NCBI) databases. Please see https://journals.plos.org/plosmedicine/s/submission-guidelines#loc-references for further guidance.

Figures

Figure 1 - please correct DALYs on the y axis

Supplementary files:

Line 302 - “We have provided the code and data set in our online appendix. “ Please ensure that either the relevant file is appended to your resubmission, or that the freely / publicly available location of the data is shared in your manuscript. The file ‘Data Dictionary and R Code Publication-adf-ns.docx.pdf’ appears to be an unrevised version of your manuscript.

Any attachments provided with reviews can be seen via the following link:

[LINK]

Decision Letter 4

Louise Gaynor-Brook

25 May 2021

Dear Dr Jensen, 

On behalf of my colleagues and the Academic Editor, Prof. Margaret Kruk, I am pleased to inform you that we have agreed to publish your manuscript "Conflict-related intentional injuries in Baghdad, Iraq 2003-2014: A modeling study and proposed method for calculating burden of injury in conflict" (PMEDICINE-D-20-02532R4) in PLOS Medicine.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. Please be aware that it may take several days for you to receive this email; during this time no action is required by you. Once you have received these formatting requests, please note that your manuscript will not be scheduled for publication until you have made the required changes.

In the meantime, please log into Editorial Manager at http://www.editorialmanager.com/pmedicine/, click the "Update My Information" link at the top of the page, and update your user information to ensure an efficient production process. 

PRESS

We frequently collaborate with press offices. If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximise its impact. If the press office is planning to promote your findings, we would be grateful if they could coordinate with medicinepress@plos.org. If you have not yet opted out of the early version process, we ask that you notify us immediately of any press plans so that we may do so on your behalf.

We also ask that you take this opportunity to read our Embargo Policy regarding the discussion, promotion and media coverage of work that is yet to be published by PLOS. As your manuscript is not yet published, it is bound by the conditions of our Embargo Policy. Please be aware that this policy is in place both to ensure that any press coverage of your article is fully substantiated and to provide a direct link between such coverage and the published work. For full details of our Embargo Policy, please visit http://www.plos.org/about/media-inquiries/embargo-policy/.

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

Thank you again for submitting to PLOS Medicine. We look forward to publishing your paper. 

Sincerely, 

Louise Gaynor-Brook, MBBS PhD 

Associate Editor 

PLOS Medicine

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 STROBE Guidelines Checklist. Completed Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines checklist applicable to this work.

    (PDF)

    S1 Analysis Plan. Prospective analysis plan for calculation of DALYs for all injury patterns.

    (PDF)

    S1 Data Dictionary and R code Publication. Definitions of terms contained in shared data set, R code for bootstrapped calculation of incidence based DALYs, and definition of terms contained within the function.

    (PDF)

    S1 Questionnaire. English version of the survey tool designed and utilized for household survey and data collection by Lafta and colleagues during initial data collection.

    (PDF)

    S1 DALY Data. Shared data set needed for replication of this work.

    The data are provided in the csv file format.

    (CSV)

    Attachment

    Submitted filename: Response to Plos Med reviewers Jensen paper-adf_AH_Clean.docx

    Attachment

    Submitted filename: Response to Plos Med reviewers Jensen paper_November.docx

    Attachment

    Submitted filename: Response to Reviewers_Final.docx

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files.


    Articles from PLoS Medicine are provided here courtesy of PLOS

    RESOURCES